Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 54%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/8/2015 Brean Capital New Coverage Buy
(N/A)
13.00
(N/A)
9.30 4.35 -53.23% Details
6/17/2014 Mackie Research New Coverage Spec. Buy
(N/A)
9.50
(N/A)
7.01 4.35 -37.95% Details
Like CRME Ratings? Also take a look at STDY, NVTL, NVIV, OCLS

CRME Ratings News